Therapeutics - Parkinsons Flashcards

(71 cards)

1
Q

define parkinsons and name some symptoms

A

progressive neurologic disorder

tremors, rigidity, postural instability, bradykinesia (slow movement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are dopamine levels like in parkinsons patients

where? what about acetylcholine levels?

A

low

in substantia nigra

high acetylcholine (so excess cholinergic activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

true or false

most parkinsons is idiopathic

A

true - no known cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

some things that can induce parkinsons

A

heavy metals
pesticides
MPTP
CO
drugs (1st gen antipsychotics, metoclopramide, phenothiazides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

true or false

parkinsons can occur after encephalitis

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

early and late MOTOR parkinsons symptoms

A

early - cogwheel rigidity, soft voice, shuffling gair, bradykinesia, pill-rolling tremors

late - freezing, postural imbalance, hard to swallow and talk - get some cognitive deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

name some autonomic symptoms of parkinsons

A

orthostatic hypotension
constipation
hard to pee
extreme sweating
seborrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

effect of parkinsons on blood pressure

A

can cause orthostatic hypotension - even when just sitting down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hyposmia

A

nonmotor parkinsons symptom - loss of smell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 symptoms of parkinsons that may actually occur before the patient is even diagnosed

A

hyposmia (hard to smell)
REM sleep disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when a patient is “on” in parkinsons, is the medication working or not working

A

working - symptoms are controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

short term and long term goals for parkinsons treatment

A

short term - control symptoms, increase functionality

long term - limit complications, maintain effective treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

trueor false

there are several disease-modifying treatments for parkinsons

A

FALSE- none

only symptomatic relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a patient has some parkinsons symptoms with early PD (less than 5 years)… but not causing disability

what is the approach??

ie - a tremor in nondominant hand

A

wait and see approach – hold off for now

bc once we start levodopa, limited amount of time that the patient will respond

but if pt has significant issues — start LEVODOPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

in general, initial treatment with ____ provides more benefit to dopamine agonists

A

levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is considered “early” parkinsons

A

less than 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

a patient is initially started on a MAO-B inhibitor for parkinsons

what will they need in the future

A

will need additional treatment within 2-3 years — diff from patients who are started on levodopa or dopamine agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3 potential initial options for early PD

A

levodopa
dopamine agonist
MAO B inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

true or false

dopamine agonists are more likely to cause dyskinesias than levodopa

A

FALSE - levodopa is more likely to cause dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

for early PD:

levodopa vs levodopa + entacapone vs IR levodopa

which is most effective

A

all equally effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which has a higher risk of impulse control disorders — dopamine agonists or levodopa?

A

dopamine agonists have higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

if a patient is less than 60 years old with PD, explain the thought process behind what treatment to start

A

may start with a dopamine agonist over levodopa

younger people can tolerate the CNS SE of dopamine agonists more….. and also the patient is gonna be living with PD for a long time - want to try to wait to use levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

patient has a history of cognitive impairment and PD

what should we start with

A

start with levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

patient has a history of MOOD DISORDERS and PD

what should we start with

A

levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
if patient's PD disease is SEVERE, what should we start with
levodopa
26
initial therapy if the patient has TREMOR ONLY (no bradykinesia)
anticholinergics -- but only if the patient is younger!!!! dont like the anticholinergic side effects in older people
27
when may MAO-B inhibitors be used as initial therapy
really only for milder cases
28
which med is PRIMARILY for dyskinesia as an add on therapy
amantadine
29
true or false for PD, nonpharm treatment is just as important as pharmacologic
true exercise, PT, OT, speech therapy
30
3 potential add on therapies for PD
istradefylline amantadine (dyskinesia) COMT inhibitors
31
advanced therapy PD
surgical
32
2 MAO-B inhibitors that may be considered at diagnosis of PD if it is mild
rasagiline selegiline
33
true or false a dopamine agonist should only be started if the patient is under 60 what if over 60?
true if over 60 - start carbidopa/levodopa
34
after initial PD therapy, doses should be adjusted as needed and tolerated as the patient's symptoms get worse, what should be done
add another agent, then add COMT inhibitor
35
2 general concerns of PD/PD drugs
melanoma - should be checked by derm impulse control disorders (anthing that increases dopamine in the brain - includes BOTH dopamine agonists and levodopa) - urges to gamble, sexual urges, etc
36
MOA of MAO-B inhibitors
binds MAO-B enzyme - the enzyme that metabolizes (oxidizes) dopamine blocks breakdown of dopamine in the brain
37
name 3 MAO-B inhibitors
selegiline rasagiliine safinamide
38
4 drugs that should be used with caution with MAO-B inhibitors
tramadol meperidine DM SSRIS
39
which MAO-B inhibitor was originally thought to be neuroprotective but it was debunked
selegiline it was just symptomatic relief
40
only indication for ODT selegiline
in combo with levodopa later in the disease
41
important note when dosing all the MAO-B inhibitors
-DO NOT GO ABOVE THE MAX DOSE. will not be selective for B anymore. can go into hypertensive crisis
42
selegiline ADRs
hallucinations, confusion nausea INSOMNIA!!!!! - from the amphetamine-like metabolite
43
how can insomnia from selegiline be avoided
if PO version - dont give the 2nd dose after 2pm ODT formulation has less CNS stimulation
44
true or false transdermal selegiline can be used for parkinsons
FALSE - the transdermal form is only for depression
45
PO max dose selegiline ODT max dose selegiline why is it important not to go above these?
PO - 10mg ODT - 2.5mg loses specificity for MAO-B inhibition - can go into hypertensive crisis
46
use for rasagiline
monotherapy in early PD carbidopa/levodopa adjunct in moderate-advanced PD
47
max doses of rasagiline: -monotherapy -adjunct to levodopa
monotherapy - 1mg QD adjunt - 0.5mg but may increase to 1mg
48
advantages of rasagiline over selegiline
no amphetamine-like side effects (no insomnia) tyramine reaction unlikely (less CV side effects) overall - less CV and less CNS side effects
49
use of safinamide
as an adjunct to carbidopa-levidopa in patients with "off" episodes NOT USED AS MONOTHERAPY
50
true or false safinamide can be effective as monotherapy for PD
FALSE - not effective as monotherapy. only as adjunct to carb/lev in patients experiencing off episodes
51
what foods should be avoided with safinamide
very high tyramine concentration
52
dose of safinamide
50mg QD for 2 weeks increase to 100mg daily after that (100mg is MAX)
53
in what patients must safinamide be avoided
patients with severe hepatic impairment
54
safinamide ADRs
CNS depression dyskinesia impulse control disorder serotonin syndrome HTN
55
3 anticholinergics that may potentially be used for PD tremors in YOUNGER PATIENTS
diphenhydramine benztropine trihexyphenidyl
56
effect of anticholinergics on the heart
tachycardia
57
effect of anticholinergics on the eyes
dry eyes
58
any dose adjustments for amantadine?
in renal impairment (CrCl less than 60mL/min)
59
place in PD therapy for amantadine
in early disease or late, in combo with other agents monotherapy effect is short lived -- only 6 months
60
ADRs amantadine
CNS changes and similar anticholinergic effects levido reticularis (skin condition)
61
amantadine administration considerations
dont give after 2pm to avoid insomnia!!! also, older patients may not tolerate CNS side effects - not preferred
62
2 names of amantadine ER state what they're approved for
gocovri (capsule) - for dyskinesias and off episodes osmolex ER (tablet) - for PD and drug-induced EPS
63
differentiate between the dosing time of Gocovri vs Osmolex
QHS - gocovri qam - osmolex
64
dose adjustments for gocovri and osmolex
both - dose adjustment in CrCl less than 60, DO NOT USE in CrCl less than 15
65
true or false gocovri and osmolex are NOT interchangeable
true
66
____ is considered the mainstay of therapy for PD
levodopa
67
why is carbidopa given with levodopa
if we just give levodopa, it will get converted to dopamine in the periphery which we DONT WANT carbidopa prevents the peripheral conversion (breakdown) of levodopa into dopamine
68
___mg of carbidopa/day is needed to block the peripheral conversion of levodopa into dopamine
50-100mg
69
true or false carbidopa does not cross the BBB
true - this is good lveodopa does tho - which is good
70
2 formulations of carbidopa/levodopa for late stage PD to treat the motor fluctuations
enteral suspension for jejunal infusion SQ continuous infusion
71